Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
31 studies found for:    Lennox-Gastaut Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Lennox-Gastaut Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
Condition: Lennox-Gastaut Syndrome (LGS)
Interventions: Drug: Perampanel;   Drug: Placebo
2 Completed European Registry of Anti-Epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS)
Condition: Lennox-Gastaut Syndrome
Intervention:
3 Completed
Has Results
Transcranial Direct Current Stimulation, Treatment of Childhood Drug-Resistant Lennox-Gastaut Syndrome, A Pilot Study
Condition: Lennox-Gastaut Syndrome
Intervention: Device: tDCS
4 Unknown  Melatonin Versus Placebo in the Lennox-Gastaut Syndrome: Neurophysiological and Neuropsychological Effects
Condition: Lennox-Gastaut Syndrome
Interventions: Drug: melatonin;   Drug: placebo
5 Completed
Has Results
A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080-J081-304)
Condition: Lennox-Gastaut Syndrome
Interventions: Drug: Rufinamide (E2080);   Drug: Placebo
6 Completed Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs
Condition: Lennox-Gastaut Syndrome
Interventions: Drug: Rufinamide;   Drug: Any other approved AED
7 Not yet recruiting Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Subjects With Inadequately Controlled Lennox-Gastaut Syndrome
Condition: Lennox-Gastaut Syndrome
Interventions: Drug: Cannabidiol Oral Solution;   Drug: Placebo Solution
8 Completed
Has Results
Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome
Condition: Lennox-Gastaut Syndrome
Intervention: Drug: Clobazam
9 Completed A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
Conditions: Epilepsy;   Lennox-Gastaut Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo Control
10 Completed A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
Conditions: Epilepsy;   Lennox-Gastaut Syndrome
Interventions: Drug: GWP42003-P;   Drug: Placebo control
11 Enrolling by invitation An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes
Conditions: Epilepsy;   Dravet Syndrome;   Lennox-Gastaut Syndrome
Intervention: Drug: GWP42003-P
12 Completed Phase III Randomized, Double-Blind, Placebo-Controlled Study of Oral Topiramate for Lennox-Gastaut Syndrome
Condition: Lennox-Gastaut Syndrome
Intervention: Drug: topiramate
13 Recruiting Trial to Assess Vagus Nerve Stimulation Therapy in Children With Lennox-Gastaut Syndrome
Condition: Lennox-Gastaut Syndrome
Intervention: Device: PINS Vagus Nerve Stimulator
14 Completed
Has Results
Clobazam in Patients With Lennox-Gastaut Syndrome
Conditions: Epilepsy;   Epilepsy, Generalized;   Seizures
Interventions: Drug: Clobazam Low Dose;   Drug: Clobazam Medium Dose;   Drug: Clobazam High Dose;   Drug: Placebo
15 Completed A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut Syndrome
Conditions: Epilepsy;   Seizures
Intervention: Drug: topiramate
16 Completed
Has Results
Clobazam in Subjects With Lennox-Gastaut Syndrome
Conditions: Epilepsy;   Epilepsy, Generalized;   Seizures
Interventions: Drug: Clobazam Low Dose;   Drug: Clobazam High Dose
17 Recruiting Post-marketing Surveillance of Long-term Administration of Inovelon Tablets in Patients With Lennox-Gastaut Syndrome
Condition: Lennox-Gastaut Syndrome
Intervention: Drug: Rufinamide
18 Completed A Long Term Extension Study of E2080 in Lennox-Gastaut Patients
Condition: Lennox-Gastaut Syndrome
Intervention: Drug: E2080
19 Terminated
Has Results
Long-term, Open-label Safety Extension Study of Retigabine/Ezogabine in Pediatric Subjects (>= 12 Years Old) With POS or LGS
Condition: Epilepsy
Intervention: Drug: retigabine/ezogabine
20 Not yet recruiting The Pharmacokinetics of Cannabidiol (CBD) and Its Effects in Children With Severe Epilepsy
Conditions: Dravet Syndrome;   Lennox Gastaut Syndrome
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-31) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.